XCancer

[18F]-AraG PET Imaging for Enhanced Risk Stratification and Chemoradiotherapy Response Assessment in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Description:

This study will use [18F]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.

Sponsor:

Indiana University

Phase:

Early Phase 1

Contacts:

Kathryn I Lauer

kilauer@iu.edu

(317) 962-8969

Government Study Link:

NCT07168785 - Click here to see study on

ClinicalTrials.gov

[18F]-AraG

Isotope(s):
Target(s):
  • Activated T-Cells